Definium Therapeutics, Inc.

DFTX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jun 12, 2024 4
4 Jun 12, 2024 4
4 Jun 12, 2024 4
4 Jun 12, 2024 4
8-K Jun 11, 2024 8-K
10-Q May 8, 2024 10-Q
8-K May 8, 2024 8-K
424B3 Apr 30, 2024 424B3
424B3 Apr 30, 2024 424B3
EFFECT Apr 29, 2024
CORRESP Apr 26, 2024
ARS Apr 26, 2024 ARS
DEFA14A Apr 26, 2024 DEFA14A
DEF 14A Apr 26, 2024 DEF 14A
UPLOAD Apr 9, 2024
S-3 Apr 2, 2024 S-3
8-K Apr 1, 2024 8-K
4 Mar 26, 2024 4
4 Mar 26, 2024 4
4 Mar 26, 2024 4
144 Mar 25, 2024
144 Mar 25, 2024
SC 13G Mar 21, 2024
D Mar 18, 2024
SC 13G Mar 15, 2024
← Newer Page 9 of 21 · 506 filings Older →